Symbolbild · KI-generiert
Simulations Plus, Inc.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Simulations Plus develops software platforms and consulting services for the pharmaceutical and biotechnology industries, with a particular focus on modelling and simulation of the pharmacokinetics of drug candidates. Products such as GastroPlus and ADMET Predictor are used in preclinical and clinical drug development. The company serves customers at regulatory agencies, pharmaceutical companies and universities worldwide.
Short profile generated automatically and checked for plausibility. A full editorial profile follows once we cover the company.
Share price
Price data from TradingView, possibly delayed. Not investment advice.
Comparable companies
Companies in the Artificial Intelligence & Software sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| Simulations Plus, Inc. | SLP | NASDAQ | 369 Mio. USD |
| Bumble | BMBL | NASDAQ | 372 Mio. USD |
| Xperi Inc. | XPER | NYSE | 372 Mio. USD |
| Materialise NV | MTLS | NASDAQ | 375 Mio. USD |
| Ribbon Communications Inc. | RBBN | NASDAQ | 377 Mio. USD |
| Cerence Inc. | CRNC | NASDAQ | 385 Mio. USD |
| Xerox | XRX | NYSE | 386 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.